Core Insights - BIO-key International, Inc. reported a decrease in total revenues for Q3'25, amounting to $1.55 million, down from $2.14 million in Q3'24, primarily due to the absence of large orders received in the previous year [3][12] - The company anticipates a strong finish to 2025, projecting full-year revenues between $6.5 million and $7 million, with expectations for continued growth into 2026 [11] Financial Performance - Q3'25 revenues decreased by 27.5% year-over-year, driven by a decline in license fee revenue, which fell by $523,060 to $917,951 from $1,441,011 in Q3'24 [12][13] - Hardware sales decreased by 17% to $363,642 in Q3'25 from $436,222 in Q3'24 [13] - Services revenues saw a slight increase to $268,113 in Q3'25 compared to $267,371 in Q3'24, with growth in recurring service revenue offsetting a decline in non-recurring custom service revenue [14] Cost Management - Total operating expenses decreased by 7.8% to $2,083,908 in Q3'25 from $2,260,099 in Q3'24, with SG&A expenses down by 13% [15] - Research, Development, and Engineering (RD&E) expenses increased by 4.6%, reflecting ongoing investment in next-generation products [15] Net Loss and Share Performance - The net loss for Q3'25 was $964,849, or $0.15 per share, compared to a net loss of $738,959, or $0.39 per share, in Q3'24 [16][29] - For the nine months ended September 30, 2025, the net loss improved to $2,868,790, or $0.50 per share, compared to $2,916,195, or $1.69 per share, in the same period of the previous year [16][29] Balance Sheet and Cash Flow - As of September 30, 2025, total current assets were $3.7 million, including $2.0 million in cash and cash equivalents, compared to total current assets of $1.9 million at the end of 2024 [17] - The company raised $3.1 million in gross proceeds from a warrant exercise agreement on October 27, 2025, which is not reflected in the Q3'25 financial statements [19] Strategic Initiatives - BIO-key launched its CyberDefense Initiative to capitalize on expected increases in global defense spending, particularly in Europe and the Middle East [6] - The company secured a significant biometric authentication deployment with a major new customer in the Middle East defense sector, enhancing its presence in high-assurance government and defense environments [7][8]
Digital Identity and Biometric Access Management Provider BIO-key Reports Q3 Results; Highlights Enhanced Post Quarter Balance Sheet to Support 2026 Growth Goals; Holds Investor Call 10am ET Today